Applied Genetic Technologies Corp (AGTC):企業の財務・戦略的SWOT分析

◆英語タイトル:Applied Genetic Technologies Corp (AGTC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15099
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pigmentosa, alpha-1 antitrypsin deficiency and macular degeneration, among others. AGTC’s achromatopsia provides treatment inherited conditions that are associated with visual acuity loss, extreme light sensitivity resulting in daytime blindness, and total loss of color discrimination. The company’s x-linked retinoschisis offers treatment in retinal degeneration affecting young males, presenting with poor vision by school age. It also offers ophthalmology development programs and proof-of-concept data in multiple indications. The company operates through its offices in Alachua and Cambridge, the US, and others. AGTC is headquartered in Alachua, Florida, the US.

Applied Genetic Technologies Corp Key Recent Developments

Feb 07,2019: AGTC announces financial results and business update for the quarter ended December 31, 2018
Sep 24,2018: AGTC names William Aliski to its board of directors
Sep 10,2018: AGTC announces financial results and business update for the fourth quarter and fiscal year ended June 30, 2018
Jun 14,2018: AGTC Announces Expansion of Clinical and Regulatory Leadership Teams
May 08,2018: AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018

This comprehensive SWOT profile of Applied Genetic Technologies Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Applied Genetic Technologies Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Applied Genetic Technologies Corp – Key Information
Applied Genetic Technologies Corp – Overview
Applied Genetic Technologies Corp – Key Employees
Applied Genetic Technologies Corp – Key Employee Biographies
Applied Genetic Technologies Corp – Key Operational Heads
Applied Genetic Technologies Corp – Major Products and Services
Applied Genetic Technologies Corp – History
Applied Genetic Technologies Corp – Company Statement
Applied Genetic Technologies Corp – Locations And Subsidiaries
Applied Genetic Technologies Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Applied Genetic Technologies Corp – Business Description
Applied Genetic Technologies Corp – Corporate Strategy
Applied Genetic Technologies Corp – SWOT Analysis
SWOT Analysis – Overview
Applied Genetic Technologies Corp – Strengths
Applied Genetic Technologies Corp – Weaknesses
Applied Genetic Technologies Corp – Opportunities
Applied Genetic Technologies Corp – Threats
Applied Genetic Technologies Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Applied Genetic Technologies Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Applied Genetic Technologies Corp, Key Information
Applied Genetic Technologies Corp, Key Ratios
Applied Genetic Technologies Corp, Share Data
Applied Genetic Technologies Corp, Major Products and Services
Applied Genetic Technologies Corp, History
Applied Genetic Technologies Corp, Key Employees
Applied Genetic Technologies Corp, Key Employee Biographies
Applied Genetic Technologies Corp, Key Operational Heads
Applied Genetic Technologies Corp, Other Locations
Applied Genetic Technologies Corp, Subsidiaries
Applied Genetic Technologies Corp, Key Manufacturing facilities
Applied Genetic Technologies Corp, Key Competitors
Applied Genetic Technologies Corp, SWOT Analysis
Applied Genetic Technologies Corp, Ratios based on current share price
Applied Genetic Technologies Corp, Annual Ratios
Applied Genetic Technologies Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Applied Genetic Technologies Corp, Performance Chart
Applied Genetic Technologies Corp, Ratio Charts

★海外企業調査レポート[Applied Genetic Technologies Corp (AGTC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SMRT Corporation Ltd.:戦略・SWOT・企業財務分析
    SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shanghai Pharmaceutical Co Ltd (601607)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Pharmaceutical Co Ltd (Shanghai Pharma) is a manufacturer, retailer, wholesaler and distributor of healthcare products. It carries out the research and development, manufacture and sale of pharmaceutical products for treating cancer, central nervous system (CNS) disorders and diseas …
  • Cellink AB (CLNK B):企業の財務・戦略的SWOT分析
    Cellink AB (CLNK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ernst & Young Global Ltd:企業の戦略・SWOT・財務分析
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Insmed Inc (INSM):製薬・医療:M&Aディール及び事業提携情報
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline are bein …
  • Sino Hotels (Holdings) Limited:企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Esperion Therapeutics Inc (ESPR)-製薬・医療分野:企業M&A・提携分析
    Summary Esperion Therapeutics Inc (Esperion) is a pharmaceutical company that develops and commercializes oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). The company’s lead product candidate, Bempedoic acid, an ATP-citrate lyase inhibitor which is in Phase …
  • Mylan Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mylan Pharmaceuticals Pvt Ltd (Mylan), a subsidiary of Mylan NV, is a pharmaceutical company that manufactures generic, speciality and active pharmaceutical ingredients (API). The company provides products such as critical care products, hepato care products, HIV care products, onco care pro …
  • Electricidade de Mocambique EP-エネルギー分野:企業M&A・提携分析
    Summary Electricidade de Mocambique EP (EDM) is a state owned vertically integrated energy utility that generates, distributes, transmits, and commercializes electricity. The company produces electricity from hydro and thermal sources. It has interests in Lichinga, Cuamba, Corumana, Chicamba, and Ma …
  • Rexnord Corp (RXN):電力:M&Aディール及び事業提携情報
    Summary Rexnord Corp (Rexnord) offers process and motion control, and water management products. The company designs, manufactures, markets and services mechanical components, and water flow control and conservation products. Its product portfolio includes motion control products, aerospace componen …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Arsenal Medical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Arsenal Medical Inc (Arsenal) is a platform technology company that develops novel therapeutic polymer based foams. The company’s products include in-situ forming materials, in-situ forming polymeric foam and in-situ curing elastomeric polymer material. It offers in-situ forming materials to …
  • QEP Resources Inc (QEP):企業の財務・戦略的SWOT分析
    QEP Resources Inc (QEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Boralex Inc:企業の発電所・SWOT分析2018
    Boralex Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • TauRx Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • CKE Restaurants Holdings Inc.:企業の戦略・SWOT・財務分析
    CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Edesa Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Edesa Biotech Inc (Edesa Biotech) is clinical-stage pharmaceutical company that endeavors to develop late stage prescription drugs for dermatological and anorectal indications. It strives to develop safe and effective alternatives to steroids. The company’s product pipeline includes EB01, a …
  • Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cheniere Energy Inc (Cheniere) is a midstream energy company that owns and operates LNG-related businesses. The company through its general partner, Cheniere Energy Partners, L.P. (Cheniere Partners) …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆